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Abstract	
Background: Recent studies have shown the immunomodulatory effect of vitamin D3 through down-regulation of 
Toll-like receptor (TLR) expression in human monocytes. In this study, the effects of vitamin D treatment on TLR2 
and TLR4 expression on monocytes derived from type 2 diabetes was investigated. Materials and Methods: To 
assess the influence of vitamin D3 on expression of TLR2 and TLR4 on monocytes from patients with type II 
diabetes, peripheral blood sample was taken of 30 patients. Peripheral blood mononuclear cells (PBMCs) were 
isolated by density gradient centrifuge and then monocytes were isolated from these cells with using the magnetic 
activated cell sorting (MACS). To investigate the effect of vitamin D3 on the expression of TLR2 and TLR4, 
monocytes were cultured in the presence of vitamin D3 (10-9 M) for 48 hours. Then the expression of TLR2 and 
TLR4 was determined by Real-time PCR. Results: We found that vitamin D3 suppresses the mRNA expression of 
TLR2 and TLR4 in patients with type II diabetes. TLR2 and TLR4 expression in the patients exposed to vitamin 
D3 were significantly decreased in comparison with patients who were not treated with vitamin D3. Conclusion: 
It can be concluded that vitamin D3 supplements may be further analyzed as a therapeutic option by reducing TLR2 
and TLR4 expression in patients with type II diabetes. 
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Diabetes is the most common chronic and 
endocrine diseases. It affects over 150 million people 
worldwide and the total number of diabetic patients 
is projected to reach 300 million by 2025 [1]. Type II 
diabetes consisted of a group of metabolic disorders 
such as hypoglycemia, inflammation, and insulin 
resistance can lead to increased risk of cardiovascular 
diseases [2]. Recent studies have been demonstrated 
that inflammation plays a crucial role in the 
development of both insulin resistance and type 2 
diabetes[3]. Activation of the innate immune system 
via toll-like receptors(TLRs) is implicated in the 
pathogenesis of insulin resistance and type2 diabetes 
[4]. TLRs were expressed on several cell type such as 
monocytes, predominant cells of the innate immune 
system that are pivotal in diabetes [5]. Activation of 
these cells through TLRs induces an immune response 
by increasing the expression of molecules MHC-I, 
MHC-II and stimulatory molecules on the surface of 
antigen-presenting cells and subsequent activation of T 
cells which in turn lead to the production of 
inflammatory cytokines such as interleukin-6 (IL-6), 
interleukin-18 (IL-18), tumor necrosis factor-α (TNF-
α), interleukin-12 (IL-12), and interferon-γ (IFN-γ) 
[6]. TLRs recognize pathogens via the pathogen-
associated molecular patterns (PAMPs). Among the 
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TLRs, TLR2, TLR4 plays an important role in the 
pathogenesis of type2 diabetes and its related 
complications [4]. TLR4 acts as a pattern-recognition 
receptors (PRRs) for lipopolysaccharide (LPS), was 
signals by both MyD88-dependent and MyD88-
independent pathways and form acomplex with MD-
2 for activation of signaling pathways. Additionally, 
TLR2 and TLR4 recognize various damage-
associated molecular patterns(DAMPs) such as heat 
shock protein 60 and 70, fatty acids, modified low-
density lipoproteins (LDLs) serum amyloid A, β-
defensin, hyaluronan, high-mobility group box 1 
(HMGB1) and extracellular matrix degradation [7, 
8]. 
Based on animal studies, identification of 
vitamin D3 receptor in pancreatic tissue and also the 
effect of vitamin D3 deficiency on insulin secretion, 
it has been suggested that there is a possible 
association between vitamin D3 and diabetes. In 
addition,it was reported that vitamin D3 deficiency 
can lead to glucose intolerance suggesting a plausible  
role of vitamin D3 in the etiology of diabetes [9]. 
Based on evidence-above mentioned, we tried to 
explore the possible association between TLR2 and  
TLR4 expression with vitamin D3 in patients with 
type II diabetes. 
Methods	
Patients. The patients consisted of 30 subjects 
with type II diabetes (13 women and 17 men; mean 
age: 42±8.2years) recruited from Diabetes Society. 
This study was approved by the ethics committee of 
Tehran University of Medical Sciences and informed 
consent was obtained from patients prior to the study 
.Then, 15 ml of peripheral blood samples was taken 
from patients following an overnight fast and 
collected in tubes containing 5% EDTA. 
Isolation of subpopulations of PBMCs and 
monocyte isolation. Mononuclear cells were isolated 
from blood by density-gradient centrifugation over 
Ficoll Hypaque, then monocytes were isolated by 
magnetic cell sorting using the Monocyte Isolation 
Kit II (Miltenyi Biotech). The purity of positively 
selected monocytes was determined by flow 
cytometry. 
Cell culture. Functional assessments were 
performed on the cultured monocytes from diabetic 
patients and CD14+ monocytes (5×106 cells) were 
resuspended in culture medium (RPMI 1640 medium 
supplemented with 2mM L-glutamine, 100 U/ml 
penicillin and 100 g/ml streptomycin) with 10% FBS. 
Then, adherent monocytes were incubated in 10% FBS 
culture medium in the presence of vitamin D3 (10-9 M) 
for 48 h. Non-treated cells was considered as controls. 
Real-time PCR. Total RNA was extracted from 
CD14+ monocytes (1×106) by using RNX Plus Kit 
(CinnaGen) according to the manufacturer’s 
instructions. Real-time-PCR was performed by using 
primers specific for TLR2, TLR4 and β-actin as 
control. The sequences of the forward and reverse 
primer used for amplification were as follows:  
TLR2 F: 5'-GGAGTTCTCCCAGTGTTTGGT-3' and 
R: 5'-GCAGTGAAAGAGCAATGGGC-3' TLR4 F: 5'-
AGAATGCTAAGGTTGCCGCT-3' and R: 5'-
CTATCACCGTCTGACCGAGC-3', β-actin F:5'-
GACCCAGATCATGTTTGAGACC-3' and R: 
5'ATCTCCTTCTGCATCCTGTCG-3'. The TLR2 and 
TLR4 mRNA expression was expressed as a ratio to β-
actin. 
Statistical analysis. Data were expressed as 
mean standard deviation (S.D). To compare variables 
between diabetic patients, we used paired t-test 
analysis. A P<0.05 was considered statistically 
significant. 
Results	
Percent of purified monocytes. After isolation 
of monocytes from PBMCs by using the Monocyte 
Isolation Kit II and an MS column, cells are 
fluorescently stained with CD14-FITC and Mouse 
IgG1 kappa isotype control. The purity of positively  
selected monocytes was determined by flow 
cytometry. The purity was 90.8 % (figure1). 
In vitro effect of vitamin D3 on TLR2 and 
TLR4 expressions. To assess the effect of vitamin D3 
on TLR2 and TLR4 expression, human monocytes 
were exposed to 10-9 M of vitamin D3. We found that 
vitamin D3 suppresses the mRNA expression of TLR2 
and TLR4 in patients with type II diabetes. TLR2 and 
TLR4 expression in the monocytes exposed to vitamin 
D3 are significantly decreased in comparison with 
monocytes not treated with vitamin D3 (P<0.05) 
(Figure 2). 
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Several studies conducted on the 
pathophysiology of type II diabetes have shown that 
diabetes is a group of metabolic disorders such as  
hyperglycemia, inflammation, and insulin resistance 
that result to increased risk of cardiovascular diseases 
[10]. Based on studies it has been suggested that, 
activation of the innate immune system by TLRs plays 
a pivotal role in the pathogenesis of insulin resistance, 
diabetes and atherosclerosis [4, 11]. Genetic studies on 
TLR4 and TLR2 polymorphisms linked with diabetes 
 
 
Figure 1. Percent of purified monocytes based on Flow cytometric analysis. Monocytes separated from PBMCs by using the Monocyte Isolation 
Kit II and an MS Column. Cells are fluorescently stained with CD14-FITC and Mouse IgG1 kappa isotype control. The purity was 90.8%. 
 
 



















































Figure 2. Decreased mRNA expression of TLR2 and TLR4 in monocytes of patients with type II diabetes after treatment with vit D3. 
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suggests that there is a connection between the TLRs 
and diabetes [12]. It has been also demonstrated that 
the activation of cells TLRs induces an immune 
response through high production of inflammatory 
cytokines such as IL-6, IL-18, TNF-α, IL-12 IFN-γ 
[13]. In a study entitled “increased expression TLR2 
in monocytes of patients with type I diabetes” was 
reported that TLR2 expression levels in diabetic 
patients is higher than in the control group. In this 
study, the patients' monocytes were isolated using 
magnetic beads, and then the monocytes were 
examined in the presence and absence of LPS [14]. 
In prospective studies by Liu et al. in 2005 and by 
Pittas et al. in 2006, about the role of vitamin D3 it 
was shown that there is an inverse relationship 
between dietary vitamin D3 and risk of type II 
diabetes [15, 16]. In a review study conducted by 
Muscogiuri et al. it was found that vitamin D3 
deficiency increases the risk of cardiovascular 
diseases and it is possible that there is an association 
between the reduced levels of vitamin D3 and 
obesity, diabetes mellitus, hyperglycemia, and 
dysfunction of vascular endothelial [17]. In a study 
entitled “the role of vitamin D3 in inflammation and 
Type II diabetes in both normal and diabetic persons” 
it was illustrated that the levels of vitamin D3 are 
important in the regulation of pathways related to 
Type II diabetes [18]. Since the activation of 
inflammatory pathways interferes with normal 
metabolism and insulin pathway this concept was 
reinforced that vitamin D3 can affect glucose 
homeostasis which were confirmed based on 
epidemiological and clinical data as well [18]. 
Accordingly, we concluded that the effect of vitamin 
D3 primarily related to its effect on insulin secretion 
and insulin sensitivity, but inflammation is related to 
the second place which is line with other studies [18]. 
In this study, we showed that monocytes of diabetic 
patients cultured in the presence vitamin D3, had 
increased expression levels of TLR2 and TLR4 in 
comparison with monocytes cultured in the absence 
of vitamin D3. These results were in agreement with 
a study in which the expression of TLR2, TLR4 and 
CD16 on monocytes from patients with Behcet's 
syndrome was assessed using flow cytometry and 
RT-PCR .The results showed that the expression 
levels of TLR 2 and TLR4 in patients with Behcet's 
syndrome are higher than the control group and 
vitamin D3 levels in these patients decreased. 
Consequently, an inverse association was found  
between vitamin D3 levels and the expression of TLR 
2 and TLR4 [19]. 
Conclusion	
So, it can be concluded that the expression level 
of TLR2 and TLR4 molecules in monocytes of 
patients with Type II diabetes was higher than healthy 
subjects, while the expression of TLR2 and TLR4 was 
reduced in the presence of vitamin D3. Therefore, it 
seems likely that the use of vitamin D3 supplements 
can greatly reduce inflammatory responses in patients 
with Type II diabetes. 
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